The goal was to rapidly develop internationally competitive retinal implants and technologies that are shown to be clinically safe and effective in restoring sight, leading to successful commercialisation. The program focused on three devices simultaneously.
In addition to developing the hardware for these devices, our researchers:
- Designed strategies to electrically stimulate the remaining cells in the retina so visual information could be passed along the visual pathway to the brain
- Established the safety and efficacy of our technology ahead of patient tests
- Developed pre- and post-operative procedures for assessing patients
- Developed safe and reproducible surgical procedures for implanting these devices into patients.
Between 2012 -2014 a 24-electrode prototype was tested with three people in Melbourne.
Bionic Vision Technologies (BVT) Pty Ltd is a privately held Australian company that develops visual prostheses to restore vision to the blind. The devices operate by electrically stimulating the remaining retinal cells in patients with retinal degeneration.
BVT products are based on intellectual property that was generated by BVA. For more information contact BVT.
BVA Annual Reports with a list of publications can be found here :
In The Media
- A collection of media releases
- A selection of media coverage highlights
- Talks and podcasts in our multimedia section